Table 4.

Summary of recent published results (2000–2014) on SRS for prolactin-secreting pituitary adenomas.

Authors	Patients	Mean dose (Gy)	Follow-up (months)	Tumor control (%)	Biochemical remission (%)	Late toxicity (%)
						Visual	Hypopituitarism
Landolt et al., 2000	20	25	29	85	25	0	NA
Pan et al., 2000	128	31.2	33	99	41	0	NA
Izawa et al., 2000	15	23.8	>6	100	16	0	NA
Pouratian et al., 2006	23	18.6	48	89	26	7	28
Pollock et al., 2008	11	18	48	100	18 at 4 years	9.1	26 at 4 years
Castinetti et al., 2009	15	28	96	100	46.6	0	21
Jezkova et al., 2009	35	34	75.5	97	37.1	NA	NA
Tanaka et al., 2010	22	25	60	100	18	4	42 at 4 years
Leenstra et al., 2010	15	20	63	100	NA	NA	41
Sheehan et al., 2011	32	24	31	93	26	2.4	24.4
Liu et al., 2013	22	15	36	86	27.3	13.6	4.5

NA, not assessed.